Oruka Therapeutics ORKA
NASDAQ ORKA
$80.83 +0.91 (+1.14%)
As of: Oct 22, 2026 · 2:28 PM EDT

Oruka Therapeutics (ORKA) Long-Term Debt Issuances (2024)

Updated

Oruka Therapeutics (ORKA) recorded Long-Term Debt Issuances of $24.98 million in FY2024.

Analysis

Oruka Therapeutics (ORKA) Long-Term Debt Issuances (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn -
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn -
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn -
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn -
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn -
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Oruka Therapeutics 5.08 Bn 3.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 24.98 Mn
API Access

Oruka Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ORKA&period=max&api_key=YOUR_API_KEY